|
MO19-2 INSIGHT2: Tepotinib + osimertinib in pts with EGFR-mutant NSCLC and acquired resistance to 1L osimertinib due to METamp |
|
|
|
Title: |
MO19-2 INSIGHT2: Tepotinib + osimertinib in pts with EGFR-mutant NSCLC and acquired resistance to 1L osimertinib due to METamp |
Author: |
Morise, Masahiro Sakai, Hiroshi Kato, Terufumi Tokito, Takaaki Takeda, Masayuki Tanaka, Hiroshi Chikamori, Kenichi Daga, Haruko Kijima, Takashi Ohashi, Kadoaki Karachaliou, Niki Ellers-Lenz, Barbara Wu, Yi-Long |
Appeared in: |
Annals of oncology |
Paging: |
Volume 32 () nr. S4 pages S309 |
Year: |
2021 |
Contents: |
|
Publisher: |
European Society for Medical Oncology |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|